Evidence map›Paper›PMID 19050258›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2008

Preferential use of DH reading frame 2 alters B cell development and antigen-specific antibody production.

Robert L Schelonka, Michael Zemlin, Ryoki Kobayashi, Gregory C Ippolito, Yingxin Zhuang, G Larry Gartland, Alex Szalai, Kohtaro Fujihashi, Klaus Rajewsky, Harry W Schroeder

Open access · greenAbstract readComparative Study
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Sex Influences Age-Related Changes in Natural Antibodies and CD5Journal of immunology (Baltimore, Md. : 1950) · 2022
    Article
  6. Article
  7. Replacement of TCR Dβ With Immunoglobulin DFrontiers in immunology · 2020
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Robert L SchelonkaDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Michael Zemlin
Ryoki Kobayashi
Gregory C Ippolito
Yingxin Zhuang
G Larry Gartland
Alex Szalai
Kohtaro Fujihashi
Klaus Rajewsky
Harry W Schroeder
University of Alabama at Birmingham · USHarvard University · USPhilipps University of Marburg · DE

Funding

IMMUNOLOGIC DISEASES AND BASIC IMMUNOLOGYT32AI007051 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Laurie Ellen Harrington · 1985 to 2026
$13.1M
The role of Immunoglobulin CDRH3 in Autoimmune DiseaseR01AI048115 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SCHROEDER, HARRY WILLIAM · 2000 to 2010
$3.1M
DEVELOPMENT OF THE ANTIBODY REPERTOIRER01AI047322 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SCHROEDER, HARRY WILLIAM · 2001 to 2005
$1.5M
Role of CDR3 in the Development of Neonatal ImmunityK08HD043327 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SCHELONKA, ROBERT LEWIS · 2003 to 2007
$582k
Role of immunoglobulin CDR-H3 in heterosubtypic immunity to influenza virusR21AI088498 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SCHROEDER, HARRY WILLIAM · 2010 to 2011
$401k
The Role of Immunoglobulin CDRH3 in Autoimmune DiseaseR56AI048115 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SCHROEDER, HARRY WILLIAM · 2012 to 2012
$366k
TRANSGENIC STUDIES OF B CELL DEVELOPMENT AND H CDR3F06TW002130 · FIC · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SCHROEDER, HARRY WILLIAM · 1995 to 1995
–
FIC NIH HHS F06 TW002130FIC NIH HHS TW02130NIAID NIH HHS AI07051NIAID NIH HHS AI42732NIAID NIH HHS AI48115NIAID NIH HHS R01 AI047322NIAID NIH HHS R01 AI048115NIAID NIH HHS R21 AI088498NIAID NIH HHS T32 AI007051NICHD NIH HHS HD043327NICHD NIH HHS K08 HD043327
6 · The paper itself

Abstract

All jawed vertebrates limit use of D(H) reading frames (RFs) that are enriched for hydrophobic amino acids. In BALB/c mice, DFL16.1 RF2 encodes valine and isoleucine. To test whether increased use of RF2 affects B cell function, we examined B cell development and Ab production in mice with an IgH allele (DeltaD-DmicroFS) limited to use of a single, frameshifted DFL61.1 gene segment. We compared the results of these studies to wild-type mice, as well as those previously obtained in mice limited to use of either a single normal D(H) or a single inverted D(H) that forces use of arginine in CDR-H3. All three of the mouse strains limited to a single D(H) produced fewer immature B cells than wild type. However, whereas mice limited to a single normal D(H) achieved normal B cell numbers in the periphery, mice forced to preferentially use RF2 had reduced numbers of mature B cells in the spleen and bone marrow, mirroring the pattern previously observed in mice enriched for charged CDR-H3s. There were two exceptions. B cells in the mice using RF2 normally populated the marginal zone and peritoneal cavity, whereas mice using inverted RF1 had increased numbers of marginal zone B cells and decreased numbers of B1a cells. When challenged with several T-dependent or T-independent Ags, Ag-specific Ab titers in the mice forced to use RF2 were altered. These findings indicate that B cell development and Ag-specific Ab production can be heavily influenced by the global amino acid content of the CDR-H3 repertoire.

Indexed as

Gene Rearrangement, B-Lymphocyte, Heavy ChainAnimalsAntibody DiversityB-Lymphocyte SubsetsCell DifferentiationComplementarity Determining RegionsEpitopes, B-LymphocyteFemaleFrameshift MutationImmunoglobulin Heavy ChainsMiceMice, Inbred BALB CMice, Mutant StrainsReading FramesComplementarity Determining RegionsEpitopes, B-LymphocyteImmunoglobulin Heavy Chains

Identifiers

PMID19050258
PMCPMC2679994
OpenAlexW2138552598

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.